207 related articles for article (PubMed ID: 27485121)
1. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
Sas-Chen A; Aure MR; Leibovich L; Carvalho S; Enuka Y; Körner C; Polycarpou-Schwarz M; Lavi S; Nevo N; Kuznetsov Y; Yuan J; Azuaje F; ; Ulitsky I; Diederichs S; Wiemann S; Yakhini Z; Kristensen VN; Børresen-Dale AL; Yarden Y
EMBO Mol Med; 2016 Sep; 8(9):1052-64. PubMed ID: 27485121
[TBL] [Abstract][Full Text] [Related]
2. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
3. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
[TBL] [Abstract][Full Text] [Related]
4. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
5. Portraying breast cancers with long noncoding RNAs.
Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
[TBL] [Abstract][Full Text] [Related]
6. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of novel lncRNA NLIPMT inhibits metastasis by reducing phosphorylated glycogen synthase kinase 3β in breast cancer.
Jiang Y; Lin L; Zhong S; Cai Y; Zhang F; Wang X; Miao R; Zhang B; Gao S; Hu X
J Cell Physiol; 2019 Jul; 234(7):10698-10708. PubMed ID: 30417392
[TBL] [Abstract][Full Text] [Related]
8. A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
He Y; Li X; Meng Y; Fu S; Cui Y; Shi Y; Du H
J Cell Biochem; 2019 Oct; 120(10):16692-16702. PubMed ID: 31095790
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of pluripotent long noncoding RNA ES3 in HER2-positive breast cancer.
Keshavarz M; Asadi MH; Riahi-Madvar A
J Cell Biochem; 2019 Oct; 120(10):18398-18405. PubMed ID: 31211468
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Su X; Malouf GG; Chen Y; Zhang J; Yao H; Valero V; Weinstein JN; Spano JP; Meric-Bernstam F; Khayat D; Esteva FJ
Oncotarget; 2014 Oct; 5(20):9864-76. PubMed ID: 25296969
[TBL] [Abstract][Full Text] [Related]
13. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Bradford JR; Cox A; Bernard P; Camp NJ
PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications.
Han YJ; Boatman SM; Zhang J; Du XC; Yeh AC; Zheng Y; Mueller J; Olopade OI
Sci Rep; 2018 Oct; 8(1):15572. PubMed ID: 30349062
[TBL] [Abstract][Full Text] [Related]
15. Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Milevskiy MJ; Al-Ejeh F; Saunus JM; Northwood KS; Bailey PJ; Betts JA; McCart Reed AE; Nephew KP; Stone A; Gee JM; Dowhan DH; Dray E; Shewan AM; French JD; Edwards SL; Clark SJ; Lakhani SR; Brown MA
Hum Mol Genet; 2016 Aug; 25(15):3269-3283. PubMed ID: 27378691
[TBL] [Abstract][Full Text] [Related]
16. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.
Wasson MD; Venkatesh J; Cahill HF; McLean ME; Dean CA; Marcato P
Gene; 2024 Apr; 901():148165. PubMed ID: 38219875
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
20. Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer.
Li J; Wang W; Xia P; Wan L; Zhang L; Yu L; Wang L; Chen X; Xiao Y; Xu C
Int J Cancer; 2018 Nov; 143(9):2150-2160. PubMed ID: 29707762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]